← Back to headlines
Barclays Predicts 45% Surge for Ionis Stock, Targeting $106
Barclays analysts believe Ionis Pharmaceuticals is poised for a significant 45% surge, projecting its stock price to rise from $73 to $106.
26 Mar, 15:27 — 26 Mar, 15:27
Sources
Showing 1 of 1 sources
